Simulations Plus, Inc.SLPEarnings & Financial Report
Simulations Plus, Inc. develops absorption, distribution, metabolism, excretion, and toxicity (ADMET) modeling and simulation software for the pharmaceutical and biotechnology, industrial chemicals, cosmetics, food ingredients, and herbicide industries. In September 2014, the company acquired Cognigen Corporation, a provider of clinical trial data analysis and consulting services.
SLP Q1 FY2026 Key Financial Metrics
Revenue
$18.4M
Gross Profit
$10.9M
Operating Profit
$713.0K
Net Profit
$676.0K
Gross Margin
59.1%
Operating Margin
3.9%
Net Margin
3.7%
YoY Growth
-2.7%
EPS
$0.03
Simulations Plus, Inc. Q1 FY2026 Financial Summary
Simulations Plus, Inc. reported revenue of $18.4M (down 2.7% YoY) for Q1 FY2026, with a net profit of $676.0K (up 228.2% YoY) (3.7% margin). Cost of goods sold was $7.5M, operating expenses totaled $10.2M.
Key Financial Metrics
| Total Revenue | $18.4M |
|---|---|
| Net Profit | $676.0K |
| Gross Margin | 59.1% |
| Operating Margin | 3.9% |
| Report Period | Q1 FY2026 |
Revenue Breakdown
Simulations Plus, Inc. Q1 FY2026 revenue of $18.4M breaks down across 3 segments, led by Services Segment at $9.5M (51.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Services Segment | $9.5M | 51.8% |
| Development | $7.2M | 39.3% |
| Discovery | $1.3M | 7.2% |
Simulations Plus, Inc. Revenue by Segment — Quarterly Trend
Simulations Plus, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Services Segment and Development) has evolved quarter over quarter.
| Segment | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 |
|---|---|---|---|---|
| Services Segment | $9.5M | $8.4M | $7.7M | $8.9M |
| Development | $7.2M | — | — | — |
| Discovery | $1.3M | — | — | — |
Simulations Plus, Inc. Annual Revenue by Year
Simulations Plus, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $79.2M).
Simulations Plus, Inc. Quarterly Revenue & Net Profit History
Simulations Plus, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q1 FY2026 | $18.4M | -2.7% | $676.0K | 3.7% |
| Q4 FY2025 | $17.5M | -6.5% | $-681.0K | -3.9% |
| Q3 FY2025 | $20.4M | +9.8% | $-67.3M | -330.6% |
| Q2 FY2025 | $22.4M | +22.5% | $3.1M | 13.7% |
| Q1 FY2025 | $18.9M | +30.5% | $206.0K | 1.1% |
| Q4 FY2024 | $18.7M | +19.4% | $843.0K | 4.5% |
| Q3 FY2024 | $18.5M | +14.2% | $3.1M | 16.9% |
| Q2 FY2024 | $18.3M | +16.2% | $4.0M | 22.0% |
Income Statement
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $18.3M | $18.5M | $18.7M | $18.9M | $22.4M | $20.4M | $17.5M | $18.4M |
| YoY Growth | 16.2% | 14.2% | 19.4% | 30.5% | 22.5% | 9.8% | -6.5% | -2.7% |
Balance Sheet
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $194.0M | $192.7M | $196.6M | $196.9M | $201.4M | $134.4M | $131.9M | $137.8M |
| Liabilities | $16.9M | $11.8M | $14.2M | $12.2M | $11.9M | $10.6M | $7.1M | $10.7M |
| Equity | $177.0M | $180.9M | $182.4M | $184.7M | $189.5M | $123.8M | $124.8M | $127.1M |
Cash Flow
| Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $5.8M | $5.7M | $1.7M | $-1.3M | $5.7M | $8.1M | $5.6M | $4.2M |